Organigram Global Inc. Announces Leadership Transition as Growth Accelerates Under CEO Beena Goldenberg
- CEO Beena Goldenberg will retire on September 30, 2025, after leading Organigram's significant revenue growth.
- Organigram's revenue increased from $80 million to over $250 million, driven by strategic initiatives and acquisitions.
- The company is expanding internationally, with recent successes in Germany, the UK, Australia, and its first U.S. revenue.
Organigram Global Inc. Prepares for Leadership Transition Amidst Growth Surge
Organigram Global Inc., a leading player in the Canadian cannabis industry, announces the upcoming retirement of CEO Beena Goldenberg, effective September 30, 2025. Goldenberg, who has been at the helm since September 2021, has spearheaded a remarkable transformation of the company. Under her leadership, Organigram has seen its net revenue surge from $80 million to over $250 million, establishing itself as a dominant force in the market. This impressive growth is attributed to several strategic initiatives, including the doubling of cultivation capacity at its Moncton, New Brunswick facility and the execution of three key acquisitions, which have enhanced its product offerings in vapes, hash, and pre-rolls.
Goldenberg's tenure also marks significant advances in Organigram's international outreach. The company has successfully tapped into markets in Germany, the UK, and Australia, expanding its global footprint. A notable highlight of her leadership is the recent acquisition of Collective Project, which signifies Organigram's first revenue recognition from the U.S. market. This strategic move not only broadens the company’s product portfolio but also positions it favorably within the rapidly evolving American cannabis landscape. As the company prepares for this leadership change, the Board has expressed strong confidence in its strategic direction and growth trajectory, indicating a robust foundation for the next phase of development.
In anticipation of her departure, Goldenberg is committed to ensuring a seamless transition for her successor. She plans to remain actively involved in driving the company's growth and profitability over the next four months, ensuring that Organigram continues on its upward trajectory. The company's recent financial results underscore this momentum, with a remarkable 74% year-over-year increase in net revenue reported in its second quarter, reflecting the effectiveness of its growth strategies. Peter Amirault, Chairman of the Board, commends Goldenberg's leadership and expresses optimism about the company's future under new leadership.
As Organigram looks to the future, the search for Goldenberg's successor is underway, highlighting the company's dedication to maintaining its market leadership and expanding its international presence. The cannabis industry is evolving rapidly, and Organigram's strategic initiatives under Goldenberg have set a strong precedent for continued innovation and growth. The upcoming leadership transition represents both a challenge and an opportunity for the company as it seeks to sustain its momentum in the competitive cannabis landscape.